Evidence map›Paper›PMID 36404925›Full record

ArticleiScience2022

A role for endothelial alpha-mannosidase MAN1C1 in radiation-induced immune cell recruitment.

Ségolène Ladaigue, Anne-Charlotte Lefranc, Khadidiatou Balde, Monica Quitoco, Emilie Bacquer, Didier Busso, Guillaume Piton, Jordane Dépagne, Nathalie Déchamps, Nao Yamakawa and 9 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Ségolène LadaigueInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Anne-Charlotte LefrancInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Khadidiatou BaldeInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Monica QuitocoInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Emilie BacquerInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Didier BussoCIGEx, Université de Paris, Université Paris-Saclay, Inserm, CEA, Institut de Biologie François Jacob, iRCM, UMR Genetic Stability, Stem Cells and Radiation (SGCSR), Fontenay-aux-Roses, France.
Guillaume PitonCIGEx, Université de Paris, Université Paris-Saclay, Inserm, CEA, Institut de Biologie François Jacob, iRCM, UMR Genetic Stability, Stem Cells and Radiation (SGCSR), Fontenay-aux-Roses, France.
Jordane DépagneCIGEx, Université de Paris, Université Paris-Saclay, Inserm, CEA, Institut de Biologie François Jacob, iRCM, UMR Genetic Stability, Stem Cells and Radiation (SGCSR), Fontenay-aux-Roses, France.
Nathalie DéchampsInstitut de Biologie François Jacob (IBFJ), Institute of Cellular and Molecular Radiobiology, CEA, UMR967 INSERM, 96265 Fontenay-aux-Roses, France.
Nao YamakawaUniversité de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000 Lille, France.
Louise DebusschereUniversité de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000 Lille, France.
Chunxue HanUniversité de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000 Lille, France.
Fabrice AllainUniversité de Lille, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France.
Valérie BuardInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Georges TarletInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Agnès FrançoisInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Vincent PagetInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Fabien MilliatInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Olivier GuipaudInstitut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE/SERAMED/LRMed, 92260 Fontenay-aux-Roses, France.
Institut de Radioprotection et de Sûreté Nucléaire · FRInserm · FRCentre National de la Recherche Scientifique · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy damages tumors and normal tissues, probably in part through the recruitment of immune cells. Endothelial high-mannose N-glycans are, in particular, involved in monocyte-endothelium interactions. Trimmed by the class I α-mannosidases, these structures are quite rare in normal conditions. Here, we show that the expression of the endothelial α-mannosidase MAN1C1 protein decreases after irradiation. We modeled two crucial steps in monocyte recruitment by developing

Indexed as

BiochemistryCell biologyFunctional aspects of cell biologyImmunology

Identifiers

PMID36404925
PMCPMC9668741
OpenAlexW4308156712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.